Advertisement

Purification of Fibronectin from Human Plasma

  • Saverio Francesco Retta
  • Piercarlo Ferraris
  • Guido Tarone
Part of the Methods in Molecular Biology book series (MIMB, volume 96)

Abstract

Fibronectin is an ubiquitous extracellular glycoprotein that exists in a soluble form in body fluids and in an insoluble form in the extracellular matrix. It plays a major role in many important physiological processes, such as embryogen-esis, wound healing, hemostasis, and thrombosis (1). Fibronectin is secreted as a dimer, with a monomer molecular weight of approx 220–250 kDa; the monomers are joined by two disulfide bonds near the carboxyl terminus of the protein (2). Like many proteins of the extracellular matrix, fibronectin is a mosaic protein composed of modular units (3). Fibronectin is composed almost entirely of three types of modules (types 1–3). The modules are organized into functional domains that are resistant to proteolysis and contain binding sites for extracellular matrix proteins such as collagen and thrombospondin, cell-surface receptors such as integrins, circulating blood proteins such as fibrin, and glycosaminoglycans such as heparin and chondroitin sulfate (4). In general, fibronectin is synthesized by and is present around fibroblasts, endothelial cells, chondrocytes, glial cells, and myocytes. Fibronectin is abundant in the connective tissue matrix and in basement membranes (5). The distribution is quite characteristic for each cell and tissue. Although blood cells, such as lymphocytes, myelocytes, and erythrocytes, lack fibronectin, this gly-coprotein is abundant in the plasma (about 30 mg/100 mL). Actually, this body fluid represents the main source for fibronectin purification.

Keywords

Chondroitin Sulfate Plasma Fibronectin Important Physiological Process Connective Tissue Matrix Monomer Molecular Weight 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Hynes, R. 0. (1990) Fibronectins. New York, Springer-Verlag.Google Scholar
  2. 2.
    Potts, J. R. and Campbell, I. D. (1994) Fibronectin structure and assembly. Curr. Opin. Cell Biol. 6, 648–55PubMedCrossRefGoogle Scholar
  3. 3.
    Engel, J. (1991) Common structural motifs in proteins of the extracellular matrix. Curr. Opin. Cell Biol. 3, 779–785.PubMedCrossRefGoogle Scholar
  4. 4.
    Mosher, D. F. (1993) Assembly of Fibronectin into Extracellular Matrix. Curr. Opin. Struct. Biol. 3, 214–222.CrossRefGoogle Scholar
  5. 5.
    Ruoslahti, E., Engvall, E., Hayman, E. (1981) Fibronectin: Current concepts of its structure and function. Collagen Res. 1, 95–128.Google Scholar
  6. 6.
    Hcipper, K. E., Adelmann, B. C., Gentner, G. and Gay, S. (1976) Recognition by guinea-pig peritoneal exudate cells of conformationally different states of the collagen molecule. Immunology 30, 249–259.Google Scholar
  7. 7.
    Engvall, E. and Ruoslabti, E. (1977) Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int. J. Cancer 20,1–5.PubMedCrossRefGoogle Scholar
  8. 8.
    Engvall, E., Ruoslahti, E., and Miller, E. J. (1978) Affinity of fibronectin to collagens of different genetic types and to fibrinogen. J. Exp. Med. 147, 1584–1595.PubMedCrossRefGoogle Scholar
  9. 9.
    Jilek, F. and Hormann, H. (1978) Fibronectin (cold-insoluble globulin), V[1]. Mediation of fibrin-monomer binding to macrophages. Hoppe Seylers Z. Physiol. Chem. 359, 1603–1605.PubMedGoogle Scholar
  10. 10.
    Dessau, W., Adelmann, B. C., Timpl, R., and Martin, G. R. (1978) Identification of the sites in collagen alpha-chains that bind serum anti-gelatin factor (cold-insoluble globulin). Biochem. J. 169, 55–59.PubMedGoogle Scholar
  11. 11.
    Vuento, M. and Vaheri, A. (1978) Dissociation of fibronectin from gelatin-agarose by amino compounds. Biochem. J. 175, 333–336.PubMedGoogle Scholar
  12. 12.
    Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: a Laboratory Manual. Cold Spring Harbour, NY, Cold Spring Harbour Laboratory.Google Scholar
  13. 13.
    Stathakis, N. E. and Mosesson, M. W. (1977) Interactions among heparin, cold insoluble globulin, and fibrinogen in formation of the heparin-precipitable fraction of plasma. J. Clin. Invest. 60, 855–865.PubMedCrossRefGoogle Scholar
  14. 14.
    Miekka, S. l., Dodd, R., Menache, D., and Ingham, K. C. (1980) An improved method for isolation of opsonically active plasma fibronectin. Fed. Proc. Fed. Am. Soc. Exp. Biol. 39, 1676.Google Scholar
  15. 15.
    Klebe, R. J., Bentley, K. L., Sasser, P. J., and Schoen, R. C. (1980) Elution of fibronectin from collagen with chaotropic agents. Exp. Cell Res. 130, 111.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 1999

Authors and Affiliations

  • Saverio Francesco Retta
    • 1
  • Piercarlo Ferraris
    • 1
  • Guido Tarone
    • 1
  1. 1.Sezione di Biologia, Dipartimento di Genetica, Biologia e Chimica MedicaUniversità di TorinoTorinoItaly

Personalised recommendations